INS and metabolic dysfunction-associated steatotic liver disease: Thus, TR agonists dissociate insulin sensitivity from fatty liver, illustrating that the relationship between TR activation and glycemia is complex and suggesting that the effect of TR agonists on insulin sensitivity must be taken into account when considering the use of these compounds for the treatment of NAFLD.